Injective price jumps as token buying pressure builds
Injective (INJ) is trading at $4.06 after surging 15.97% on the day, maintaining its position above the 20-day and 50-day moving averages, which signals continued short- and medium-term upward momentum. The price remains below the 200-day moving average at $4.90, showing that longer-term resistance persists.
Highlights
- Injective's deflationary tokenomics, including fee-based burns and staking, support gradual reduction in overall token supply.
- Ongoing discussions about institutional interest and ETF applications may influence long-term sentiment and adoption.
- INJ/USD shows robust short-term momentum and strong intraday buying, but overbought conditions and weak weekly signals imply risk of near-term consolidation between $3.20 and $4.63.
Supply contraction and staking utility bolster outlook amid ETF speculation
Injective’s tokenomics feature mechanisms such as staking, governance, and a deflationary burn process where a portion of dApp fees are used to repurchase and permanently remove tokens from circulation, contributing to a reduced overall supply. The use of auction fees for burning and ongoing staking utility supports the network’s deflationary model. Discussions regarding ETF filings and institutional involvement have been mentioned as influencing the long-term outlook.
Intraday strength persists as overbought signals threaten pullback
INJ/USD is trading above its 20-day and 50-day moving averages at $3.16 and $3.05, respectively, which confirms short- and medium-term upward momentum. The price remains under its 200-day moving average at $4.90, indicating lingering long-term resistance, while the nearest dynamic support is seen near the Ichimoku Kijun level around $3.20; the next resistance is at the round $4.50 area.
Daily momentum is firm, with the Moving Average Convergence Divergence (MACD) showing a buy signal and the Average Directional Index (ADX) still at a low 13.25, suggesting the trend lacks strong conviction. The Relative Strength Index (RSI) is approaching overbought at 66.97, and both the Stochastic RSI and Commodity Channel Index (CCI) are fully overbought, indicating short-term risk of pullback or consolidation. Bull/Bear Power (BBP) at 0.38 shows buyers clearly dominate intraday, even as oscillators flag a stretched move. The Awesome Oscillator (AO) supports the positive sentiment. The pair jumped at the open with an upside gap of about $0.04, surged 15.97% on the day to $4.06, and is trading near session highs. Intraday volatility stands at 16.24%, reflecting strong buying pressure persisting beyond the open. Momentum indicators and daily price action both confirm robust intraday strength, but overbought oscillators warn of emerging risks for short-term traders.
Earlier, analysts noted that although Injective showed some signs of short-term recovery, the broader outlook remained cautious due to persistent medium- and long-term bearish signals. The latest surge in price and sustained intraday momentum adds a new dimension to the analysis, but with overbought conditions emerging and weekly indicators still bearish, traders should monitor the $4.63 resistance level for a potential breakout or be prepared for a possible corrective pullback.
Latest Injective News
- Forex
- Crypto